查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451029

2024-2032 年按產品和服務、技術、應用、最終用戶和地區分類的細胞分析市場報告

Cell-based Assay Market Report by Product and Services, Technology, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球細胞檢測市場規模達到 225 億美元。展望未來， IMARC Group預計，到 2032 年，市場規模將達到 429 億美元，2024-2032 年複合年成長率 (CAGR) 為 7.2%。對解決各種疾病的新療法的需求不斷成長、對個性化藥物的日益關注以及提高藥物篩選準確性的細胞培養技術創新是推動市場的一些主要因素。

基於細胞的測定，也稱為細胞測定，是一種實驗室技術，用於各種科學和醫學領域，用於評估細胞對特定物質或條件的生物活性。它包括在受控環境中培養活細胞並將其暴露於各種刺激，例如藥物、化合物或環境因素。由於它使研究人員能夠透過監測細胞行為的變化（例如細胞活力或特定生物標記的表達）來深入了解被測物質對細胞功能的影響，因此全球範圍內對基於細胞的檢測的需求正在不斷增加。

目前，基於細胞的檢測方法擴大用於藥物發現、毒理學研究、疾病建模和了解細胞機制，正在支持市場的成長。除此之外，評估藥物化合物的潛在功效和安全性的需求日益成長，正在加強市場的成長。此外，對基於細胞的檢測的需求不斷成長，因為它們使研究人員能夠在開發過程的早期識別潛在的不利影響並評估化學品的毒性，正在對市場產生積極影響。除此之外，世界各地癌症、糖尿病和自體免疫疾病等多種慢性疾病的發生率不斷上升，為產業投資者提供了利潤豐厚的成長機會。此外，評估化學物質和污染物對植物和水生系統影響的需求不斷成長，也推動了市場的成長。

基於細胞的檢測市場趨勢/促進因素：

對解決各種疾病的新療法的需求不斷成長

對藥物發現和開發的日益關注，以及全球個人對解決各種慢性疾病的新療法的需求不斷增加，正在促進市場的成長。此外，基於細胞的檢測使研究人員能夠快速有效地篩選和評估大量潛在的候選藥物。透過將細胞暴露於不同的化合物，科學家可以評估它們對細胞行為的影響，包括它們的功效和安全性。除此之外，人們越來越關注精準醫學，因此需要深入了解藥物如何與特定細胞途徑相互作用。此外，這些測定提供了一個根據個別患者情況定製藥物治療的平台。

越來越重視個人化藥物

大眾對個人化藥物的日益關注正在支持市場的成長。與此一致，醫療機構正迅速專注於客製化治療解決方案，以適應個別患者的遺傳、分子和細胞特徵。除此之外，基於細胞的檢測使研究人員能夠評估患者來源的細胞對各種藥物和治療的反應，並能夠確定最有效的療法，同時最大限度地減少潛在的副作用。此外，個人化醫療不僅可以改善治療結果，還可以透過避免無效治療來降低醫療成本。因此，基於細胞的檢測在臨床和研究環境中的採用有所增加，因為它們為根據患者的特定需求量身定做醫療干預措施提供了強大的工具。

細胞培養技術的創新

細胞培養技術的進步正在增強基於細胞的檢測的能力。 3D 培養和類器官使研究人員能夠研究更接近人體的細胞行為，以提高藥物篩選和毒性測試的準確性，這提供了積極的市場前景。此外，微流體和晶片實驗室技術能夠開發小型化和自動化的基於細胞的檢測，有助於提高藥物發現的通量和效率。據此，將這些先進的細胞培養技術整合到基於細胞的檢測中有助於增強其相關性和適用性，這使它們成為了解疾病機制和更精確地評估候選藥物的合適工具。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球細胞檢測市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：按產品和服務
  • 市場區隔：按技術
  • 市場區隔：按應用
  • 市場區隔：按最終用戶
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：依產品與服務

  • 耗材
    • 試劑和介質
      • 市場走向
      • 市場預測
    • 細胞和細胞系
      • 市場走向
      • 市場預測
    • 探針和標籤
      • 市場走向
      • 市場預測
  • 儀器
    • 微孔板
      • 市場走向
      • 市場預測
    • 酶標儀
      • 市場走向
      • 市場預測
    • 高通量篩選
      • 市場走向
      • 市場預測
    • 液體處理系統
      • 市場走向
      • 市場預測
  • 服務
    • 市場走向
    • 市場預測
  • 軟體
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依技術

  • 自動化處理
    • 市場走向
    • 市場預測
  • 流式細胞儀
    • 市場走向
    • 市場預測
  • 無標記檢測
    • 市場走向
    • 市場預測
  • 高通量篩選
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 藥物發現
    • 市場走向
    • 市場預測
  • 基礎研究
    • 市場走向
    • 市場預測
  • ADME研究
    • 市場走向
    • 市場預測
  • 預測毒理學
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 學術和政府機構
    • 市場走向
    • 市場預測
  • 合約研究組織
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 11 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Becton, Dickinson and Company
    • Global Life Sciences Solutions USA LLC (DBA Cytiva)
    • Thermo Fisher Scientific Inc.
    • Merck Group
    • PerkinElmer Inc.
    • Charles River Laboratories Inc.
    • Lonza Group Ltd.
    • Cell Signaling Technology
    • Promega Corporation
    • Cell Biolabs Inc.
    • Eurofins DiscoverX Corporation
    • Bio-Rad Laboratories Inc.
    • Corning Inc.
    • F. Hoffmann-La Roche AG (Roche Holding AG)
Product Code: SR112024A1079

The global cell-based assay market size reached US$ 22.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032. The growing demand for novel therapies to address various diseases, rising focus on personalized medicines, and innovations in cell culture technologies to improve the accuracy of drug screening are some of the major factors propelling the market.

A cell-based assay, also known as a cellular assay, is a laboratory technique that is used in various scientific and medical fields to assess the biological activity of cells in response to specific substances or conditions. It comprises culturing living cells in controlled environments and exposing them to various stimuli, such as drugs, compounds, or environmental factors. As it allows researchers to gain critical insights into the effects of the tested substances on cellular function by monitoring changes in cell behavior, such as cell viability or the expression of specific biomarkers, the demand for cell-based assay is increasing worldwide.

At present, the rising adoption of cell-based assays for drug discovery, toxicology studies, disease modeling, and understanding cellular mechanisms is supporting the growth of the market. Besides this, the increasing need to evaluate the potential efficacy and safety of pharmaceutical compounds is strengthening the growth of the market. Additionally, the growing demand for cell-based assays, as they enable researchers to identify potential adverse effects early in the development process and assess the toxicity of chemicals, is positively influencing the market. Apart from this, increasing incidences of numerous chronic diseases, such as cancer, diabetes, and autoimmune disorders, among individuals around the world are offering lucrative growth opportunities to industry investors. Furthermore, the rising need to assess the impact of chemicals and pollutants on plant and aquatic systems is bolstering the growth of the market.

Cell-Based Assay Market Trends/Drivers:

Rising demand for novel therapies to address various diseases

The rising focus on drug discovery and development, along with the increasing demand for novel therapies to address various chronic diseases among individuals across the globe, is contributing to the growth of the market. In addition, cell-based assays enable researchers to screen and evaluate a vast number of potential drug candidates quickly and efficiently. By exposing cells to different compounds, scientists can assess their impact on cellular behavior, including their efficacy and safety profiles. Apart from this, there is an increase in the focus on precision medicine that necessitates a deep understanding of how drugs interact with specific cellular pathways. Moreover, these assays provide a platform for tailoring drug treatments to individual patient profiles.

Increasing focus on personalized medicines

The rising focus on personalized medicines among the masses is supporting the growth of the market. In line with this, healthcare facilities are rapidly focusing on treatment solutions that are customized to suit the genetic, molecular, and cellular characteristics of individual patients. Besides this, cell-based assays allow researchers to evaluate the response of patient-derived cells to various drugs and treatments and enable the identification of the most effective therapies while minimizing potential side effects. In addition, personalized medicine not only improves treatment outcomes but also reduces healthcare costs by avoiding ineffective treatments. As a result, there is an increase in the adoption of cell-based assays in both clinical and research settings, as they provide a powerful tool for tailoring medical interventions to the specific needs of patients.

Innovations in cell culture technologies

Advancements in cell culture techniques are enhancing the capabilities of cell-based assays. 3D cultures and organoids allow researchers to study cell behavior closer to the human body to improve the accuracy of drug screening and toxicity testing, which is offering a positive market outlook. Additionally, microfluidics and lab-on-a-chip technologies enable the development of miniaturized and automated cell-based assays that assist in increasing throughput and efficiency in drug discovery. In line with this, the integration of these advanced cell culture technologies into cell-based assays aids in enhancing their relevance and applicability, which makes them suitable tools for understanding disease mechanisms and evaluating drug candidates with greater precision.

Cell-Based Assay Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell-based assay market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and services, technology, application and end-user.

Breakup by Product and Services:

Consumables

Reagents and Media

Cells and Cell Lines

Probes and Labels

Instruments

Microplates

Microplate Readers

High Throughput Screening

Liquid Handling Systems

Services

Software

Consumables represent the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product and services. This includes consumables (reagents and media, cells and cell lines, and probes and labels), instruments (microplates, microplate readers, high throughput screening, and liquid handling systems), services, and software. According to the report, consumables represented the largest segment. Consumables refer to a wide range of disposable laboratory materials and reagents that are essential for conducting cell-based experiments and assays. They include cell culture media, reagents for cell proliferation and viability assays, cell culture plates, assay kits, antibodies, and other materials used on a one-time or limited-use basis. In addition, consumables ensure the proper growth and maintenance of cells in culture and provide the necessary tools for detecting cellular responses that enable the execution of various assays efficiently. They play a crucial role in ensuring the accuracy, reproducibility, and reliability of results in cell-based experiments.

Breakup by Technology:

Automated Handling

Flow Cytometry

Label-Free Detection

High-Throughput Screening

Others

High-throughput screening accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes automated handling, flow cytometry, label-free detection, high-throughput screening, and others. According to the report, high-throughput screening represented the largest segment. High-throughput screening (HTS) is a technology-driven approach used in drug discovery, which allows researchers to quickly test thousands to millions of compounds for their biological activity. HTS systems are designed to automate the screening process and enable the rapid evaluation of potential drug candidates. It involves the use of robotic systems and specialized equipment to perform assays on a large scale. It typically utilizes microplates with multiple wells, where each well contains cells or biochemical components for testing. The technology allows for the identification of compounds that exhibit desired biological effects, such as binding to a specific target or modulating a cellular response.

Breakup by Application:

Drug Discovery

Basic Research

ADME Studies

Predictive Toxicology

Others

Drug discovery dominates the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes drug discovery, basic research, ADME studies, predictive toxicology, and others. According to the report, drug discovery represented the largest segment. Drug discovery refers to the techniques and technologies used to administer therapeutic substances, such as drugs or biologics, to the targeted cells or tissues within the body. These assays play a critical role in the development and optimization of drug delivery systems by providing valuable insights into their efficacy and safety. In addition, they are used to assess targeted delivery, screen for cellular uptake, evaluate drug release kinetics, and assay drug toxicity. Researchers employ cell-based models to evaluate the ability of drug delivery systems, such as nanoparticles or liposomes, to specifically target and interact with particular cell types or tissues.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutions

Contract Research Organizations

Others

Pharmaceutical and biotechnology companies hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment. Pharmaceutical and biotechnology employ these assays to identify and validate potential drug candidates, assess their efficacy, and evaluate safety profiles. They enable high-throughput screening of compound libraries that enhance the drug development pipeline. In line with this, these companies utilize these assays to ensure the safety of drug candidates. These assays assist in assessing the cytotoxicity and potential adverse effects of compounds that benefit companies complying with regulatory requirements. Moreover, these assays are employed for quality control purposes to ensure the consistency and reliability of pharmaceutical and biotechnological products.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest cell-based assay market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing demand for advanced assay technologies and consumables. In addition, the rising development of novel cell-based assay techniques is bolstering the growth of the market in the region. Apart from this, the growing focus on drug safety is positively influencing the market. In line with this, stringent regulatory standards are propelling the growth of the market in the North America region.

Competitive Landscape:

Major players are developing innovative assay technologies, such as novel reagents, assay kits, and platforms. This involves creating more physiologically relevant cell models to improve assay sensitivity and enhance automation and data analysis capabilities. In line with this, companies are expanding their product portfolios to cater to a wide range of applications. This includes offering assays tailored for specific targets, pathways, or disease models, and developing specialized kits for toxicity testing and drug screening. Apart from this, key manufacturers are providing customized assay development services and are working closely with clients to tailor assays to their specific research needs, which is offering a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Becton, Dickinson and Company

Global Life Sciences Solutions USA LLC (DBA Cytiva)

Thermo Fisher Scientific Inc.

Merck Group

PerkinElmer Inc.

Charles River Laboratories Inc.

Lonza Group Ltd.

Cell Signaling Technology

Promega Corporation

Cell Biolabs Inc.

Eurofins DiscoverX Corporation

Bio-Rad Laboratories Inc.

Corning Inc.

F. Hoffmann-La Roche AG (Roche Holding AG)

Recent Developments:

In December 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. to provide a complete suite of services across the clinical development spectrum, comprising scientific discovery, safety, efficacy and healthcare outcome assessment, handling trial logistics, and the development and production of the therapeutics.

In March 2022, Promega Corporation and FUJIFILM Cellular Dynamics, Inc. announced a strategic collaboration to advance novel assay development for drug discovery. The collaboration will merge bioluminescent reporter technology used to study cellular signaling and transcriptional activity in iPSCs.

In 2022, BD (Becton, Dickinson and Company) introduced the BD Rhapsody(TM) TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system and provide a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.

Key Questions Answered in This Report

  • 1. What was the size of the global cell-based assay market in 2023?
  • 2. What is the expected growth rate of the global cell-based assay market during 2024-2032?
  • 3. What are the key factors driving the global cell-based assay market?
  • 4. What has been the impact of COVID-19 on the global cell-based assay market?
  • 5. What is the breakup of the global cell-based assay market based on the product and services?
  • 6. What is the breakup of the global cell-based assay market based on the technology?
  • 7. What is the breakup of the global cell-based assay market based on the application?
  • 8. What is the breakup of the global cell-based assay market based on the end-user?
  • 9. What are the key regions in the global cell-based assay market?
  • 10. Who are the key players/companies in the global cell-based assay market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell-Based Assay Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Services
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product and Services

  • 6.1 Consumables
    • 6.1.1 Reagents and Media
      • 6.1.1.1 Market Trends
      • 6.1.1.2 Market Forecast
    • 6.1.2 Cells and Cell Lines
      • 6.1.2.1 Market Trends
      • 6.1.2.2 Market Forecast
    • 6.1.3 Probes and Labels
      • 6.1.3.1 Market Trends
      • 6.1.3.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Microplates
      • 6.2.1.1 Market Trends
      • 6.2.1.2 Market Forecast
    • 6.2.2 Microplate Readers
      • 6.2.2.1 Market Trends
      • 6.2.2.2 Market Forecast
    • 6.2.3 High Throughput Screening
      • 6.2.3.1 Market Trends
      • 6.2.3.2 Market Forecast
    • 6.2.4 Liquid Handling Systems
      • 6.2.4.1 Market Trends
      • 6.2.4.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Automated Handling
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Label-Free Detection
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 High-Throughput Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Basic Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 ADME Studies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Predictive Toxicology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Government Institutions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Becton, Dickinson and Company
    • 11.3.2 Global Life Sciences Solutions USA LLC (DBA Cytiva)
    • 11.3.3 Thermo Fisher Scientific Inc.
    • 11.3.4 Merck Group
    • 11.3.5 PerkinElmer Inc.
    • 11.3.6 Charles River Laboratories Inc.
    • 11.3.7 Lonza Group Ltd.
    • 11.3.8 Cell Signaling Technology
    • 11.3.9 Promega Corporation
    • 11.3.10 Cell Biolabs Inc.
    • 11.3.11 Eurofins DiscoverX Corporation
    • 11.3.12 Bio-Rad Laboratories Inc.
    • 11.3.13 Corning Inc.
    • 11.3.14 F. Hoffmann-La Roche AG (Roche Holding AG)

List of Figures

  • Figure 1: Global: Cell-Based Assay Market: Major Drivers and Challenges
  • Figure 2: Global: Cell-Based Assay Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cell-Based Assay Market: Breakup by Product and Services (in %), 2023
  • Figure 4: Global: Cell-Based Assay Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Cell-Based Assay Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cell-Based Assay Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Cell-Based Assay Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cell-Based Assay Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Cell-Based Assay Industry: SWOT Analysis
  • Figure 10: Global: Cell-Based Assay Industry: Value Chain Analysis
  • Figure 11: Global: Cell-Based Assay Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Cell-Based Assay (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cell-Based Assay (Consumables- Reagents and Media) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cell-Based Assay (Consumables- Reagents and Media) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cell-Based Assay (Consumables- Cells and Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cell-Based Assay (Consumables- Probes and Labels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cell-Based Assay (Consumables- Probes and Labels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cell-Based Assay (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cell-Based Assay (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cell-Based Assay (Instruments-Microplates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cell-Based Assay (Instruments-Microplates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cell-Based Assay (Instruments-Microplate Readers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cell-Based Assay (Instruments- Microplate Readers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cell-Based Assay (Instruments-High Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cell-Based Assay (Instruments- High Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cell-Based Assay (Instruments- Liquid Handling Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cell-Based Assay (Instruments-Liquid Handling Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cell-Based Assay (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Cell-Based Assay (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Cell-Based Assay (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Cell-Based Assay (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Cell-Based Assay (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Cell-Based Assay (Automated Handling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Cell-Based Assay (Automated Handling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Cell-Based Assay (Flow Cytometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Cell-Based Assay (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Cell-Based Assay (Label-Free Detection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Cell-Based Assay (Label-Free Detection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Cell-Based Assay (High-Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Cell-Based Assay (High-Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Cell-Based Assay (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Cell-Based Assay (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Cell-Based Assay (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Cell-Based Assay (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Cell-Based Assay (Basic Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Cell-Based Assay (Basic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Cell-Based Assay (ADME Studies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Cell-Based Assay (ADME Studies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Cell-Based Assay (Predictive Toxicology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Cell-Based Assay (Predictive Toxicology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Cell-Based Assay (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Cell-Based Assay (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Cell-Based Assay (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Cell-Based Assay (Academic and Government Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Cell-Based Assay (Academic and Government Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Cell-Based Assay (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Cell-Based Assay (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Cell-Based Assay (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Cell-Based Assay (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: North America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: North America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Asia Pacific: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Asia Pacific: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Cell-Based Assay Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Cell-Based Assay Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Cell-Based Assay Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cell-Based Assay Market Forecast: Breakup by Product and Services (in Million US$), 2024-2032
  • Table 3: Global: Cell-Based Assay Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Cell-Based Assay Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Cell-Based Assay Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Cell-Based Assay Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cell-Based Assay Market: Competitive Structure
  • Table 8: Global: Cell-Based Assay Market: Key Players